Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Raf

Items 1-10 of 29

Page
per page
  1. BI-3406
    C9081 BI-3406
    Summary: A KRASSOS1 inhibitor for RAS pathway research, with nanomolar in vitro activity.
  2. Plixorafenib
    C9064 Plixorafenib
    Summary: A selective BRAF inhibitor for research use, suitable for in vitro studies of the MAPK pathway.
  3. PLX7904
    B6177 PLX7904
    Summary: paradox-breaker RAF inhibitor, potent and selective
      Soluble in DMSO
  4. LY3009120
    A8716 LY3009120
    Target: Raf
    Summary: pan-RAF and RAF dimer inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.25 mg/mL
  5. L-779,450
    B7307 L-779,450
    Summary: Raf kinase inhibitor
      Soluble in DMSO
  6. ML 786 dihydrochloride
    B7736 ML 786 dihydrochloride
    Summary: Raf kinase inhibitor
      <61.15 mg/mL
  7. B-Raf IN 1
    B4727 B-Raf IN 1
    Summary: B-Raf inhibitor
      Soluble in DMSO
  8. LGX818
    B1174 LGX818
    Target: Raf
    Summary: RAF inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥13.38 mg/mL
  9. Dabrafenib (GSK2118436)
    B1407 Dabrafenib (GSK2118436)
     3 Citation
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥26 mg/mL
  10. B-Raf inhibitor 1 dihydrochloride
    B1173 B-Raf inhibitor 1 dihydrochloride
    Summary: B-Raf inhibitor,potent and selective
      ≥53.9 mg/mL

Items 1-10 of 29

Page
per page